These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31351215)

  • 1. Central nervous system abnormalities in spinal and bulbar muscular atrophy (Kennedy's disease).
    Finsterer J; Scorza FA
    Clin Neurol Neurosurg; 2019 Sep; 184():105426. PubMed ID: 31351215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
    Finsterer J; Soraru G
    J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
    Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
    Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
    Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
    Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion.
    MacLean HE; Warne GL; Zajac JD
    J Neurol Sci; 1996 Feb; 135(2):149-57. PubMed ID: 8867071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.
    Manzano R; Sorarú G; Grunseich C; Fratta P; Zuccaro E; Pennuto M; Rinaldi C
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):808-812. PubMed ID: 29353237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kennedy's disease: expansion of the CAG trinucleotide].
    Domitrz I; Jedrzejowska M; Lipowska M; Siddique T; Kwieciński H
    Neurol Neurochir Pol; 2001; 35(1 Suppl):107-14. PubMed ID: 11732276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA).
    Suzuki K; Kastuno M; Banno H; Sobue G
    Neuropathology; 2009 Aug; 29(4):509-16. PubMed ID: 19486304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
    Matsuura T
    Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Somatic mosaicism of expanded CAG trinucleotide repeat in spinal and bulbar muscular atrophy (SBMA)].
    Tanaka F; Ito Y; Sobue G
    Nihon Rinsho; 1999 Apr; 57(4):862-8. PubMed ID: 10222780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
    Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs.
    Onodera K; Shimojo D; Ishihara Y; Yano M; Miya F; Banno H; Kuzumaki N; Ito T; Okada R; de Araújo Herculano B; Ohyama M; Yoshida M; Tsunoda T; Katsuno M; Doyu M; Sobue G; Okano H; Okada Y
    Mol Brain; 2020 Feb; 13(1):18. PubMed ID: 32070397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.
    Grunseich C; Kats IR; Bott LC; Rinaldi C; Kokkinis A; Fox D; Chen KL; Schindler AB; Mankodi AK; Shrader JA; Schwartz DP; Lehky TJ; Liu CY; Fischbeck KH
    Neuromuscul Disord; 2014 Nov; 24(11):978-81. PubMed ID: 25047668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy.
    Malik B; Devine H; Patani R; La Spada AR; Hanna MG; Greensmith L
    Sci Rep; 2019 Mar; 9(1):3539. PubMed ID: 30837566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal and bulbar muscular atrophy.
    Lieberman AP
    Handb Clin Neurol; 2018; 148():625-632. PubMed ID: 29478604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.
    Malik B; Nirmalananthan N; Bilsland LG; La Spada AR; Hanna MG; Schiavo G; Gallo JM; Greensmith L
    Hum Mol Genet; 2011 May; 20(9):1776-86. PubMed ID: 21317158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy.
    Sahashi K; Katsuno M; Hung G; Adachi H; Kondo N; Nakatsuji H; Tohnai G; Iida M; Bennett CF; Sobue G
    Hum Mol Genet; 2015 Nov; 24(21):5985-94. PubMed ID: 26231218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Adachi H; Inukai A; Sobue G
    Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.